Mandate

Vinge advises Generic Sweden AB (publ) on the sale of Generic Systems Sweden AB

June 21, 2017

Vinge advises Generic Sweden AB (publ), which is listed on First North, in connection with the sale of its consultancy business Generic Systems Sweden AB to MSC Group AB (publ). 

Generic Sweden's divestment of the consultancy business focuses the group's operations towards telecom. The purchase price consists of a cash component and shares in MSC Group AB (publ), which is listed on Nasdaq OMX Stockholm Small Cap.

The Vinge team advising Generic Sweden includes partners Jesper Ottergren (M&A) and Erik Sjöman (Capital Markets).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025